$BLISSGVS

Bliss GVS Pharma Limited is undergoing a major ownership transition, as Anupam Rasayan India Limited has moved to acquire a controlling stake. Anupam Rasayan has signed an agreement to purchase 43.30% of Bliss GVS from existing promoters and select public shareholders at ₹299 per share. Triggering SEBI’s takeover regulations, the acquirer is now launching a mandatory open offer to purchase an additional 26% of the company’s expanded voting share capital from public shareholders at the same ₹299 price. For investors, this acquisition signals a significant shift in corporate leadership, with the acquirer set to become the new promoter and gain full control. While the offer provides an immediate exit opportunity at a fixed cash price, it also marks the end of the current promoter group's tenure. Since the acquirer has stated it has no intention to delist, the company will likely continue its operations under new strategic management.